BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang SL, Gao JW, Guo Y, Feng QL, Tang JY, Yan L, Wang JF, Cheng H, Liu PM. Associations Between Metabolic Profiles and Target-Organ Damage in Chinese Individuals With Primary Aldosteronism. Front Endocrinol (Lausanne) 2020;11:547356. [PMID: 33101195 DOI: 10.3389/fendo.2020.547356] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Manosroi W, Phudphong P, Atthakomol P, Phimphilai M. The differences of serum lipid profiles between primary aldosteronism and essential hypertension: a meta-analysis and systematic review. BMC Endocr Disord 2022;22. [DOI: 10.1186/s12902-022-01135-y] [Reference Citation Analysis]
2 Stavropoulos K, Imprialos KP, Patoulias D, Katsimardou A, Doumas M. Impact of Primary Aldosteronism in Resistant Hypertension. Curr Hypertens Rep 2022. [PMID: 35445928 DOI: 10.1007/s11906-022-01190-9] [Reference Citation Analysis]
3 Manosroi W, Atthakomol P, Wattanawitawas P, Buranapin S. Differences in Glycemic Abnormalities Between Primary Aldosteronism and Essential Hypertension: A Systematic Review and Meta-Analysis. Front Endocrinol 2022;13:870047. [DOI: 10.3389/fendo.2022.870047] [Reference Citation Analysis]
4 Lin X, Ullah MHE, Wu X, Xu F, Shan S, Lei L, Yuan L, Liu J. Cerebro-Cardiovascular Risk, Target Organ Damage, and Treatment Outcomes in Primary Aldosteronism. Front Cardiovasc Med 2022;8:798364. [DOI: 10.3389/fcvm.2021.798364] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]